Gabapentin Reverses the Allodynia Produced by the Administration of Anti-GD2 Ganglioside, an Immunotherapeutic Drug
- 1 January 1998
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 86 (1) , 111-116
- https://doi.org/10.1213/00000539-199801000-00022
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the ratRegional Anesthesia & Pain Medicine, 1997
- The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic painEuropean Journal of Pharmacology, 1997
- An animal model of pain produced by systemic administration of an immunotherapeutic anti-ganglioside antibodyPain, 1997
- Electrophysiological characteristics of primary afferent fibers after systemic administration of anti-GD2 ganglioside antibodyPain, 1997
- The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed byd-serinePsychopharmacology, 1996
- Gabapentin Adjunctive Therapy in Neuropathic Pain StatesThe Clinical Journal of Pain, 1996
- GabapentinClinical Neuropharmacology, 1995
- Gabapentin in the management of reflex sympathetic dystrophyJournal of Pain and Symptom Management, 1995
- Gabapentin as add‐on therapy in refractory partial epilepsyNeurology, 1993
- A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2aCancer Immunology, Immunotherapy, 1992